Taken together, our data demonstrate the prognostic importance of ESE-1 expression level and that its utility may be closely tied to breast cancer subtypes, with its key prognostic clinical relevance being in the luminal B and the HER2 subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.